CanSino Biologics Inc
SSE:688185
CanSino Biologics Inc
SSE:688185
Price:
68.02
CNY
4.07%
Market Closed
Market Cap:
¥11B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
CanSino Biologics Inc
SSE:688185
|
CN |
Multiples-Based Value
The Multiples-Based Value of one
CanSino Biologics Inc
stock under the Base Case scenario is
56.63
CNY.
Compared to the current market price of 68.02 CNY,
CanSino Biologics Inc
is
Overvalued by 17%.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Multiples-Based Value
Base Case
56.63
CNY
Overvaluation 17%
Multiples Across Competitors
Competitors Multiples
CanSino Biologics Inc Competitors
CanSino Biologics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
CanSino Biologics Inc
SSE:688185
|
11B CNY | 11.4 | -77.7 | -52.4 | -52.4 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
829.8B USD | 12.9 | 40.6 | 27.5 | 29.3 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
579B USD | 6.2 | 21.8 | 15.1 | 18.6 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4 | 19.3 | 11.5 | 12.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
296B USD | 4.5 | 16 | 9.9 | 12.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
221.8B GBP | 5.2 | 29.9 | 16.5 | 23.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
228.6B CHF | 5.3 | 21.2 | 13.1 | 16.9 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.3 | 10 | 7.5 | 8.7 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.7B USD | 2.5 | 20.1 | 7.7 | 10.3 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
117.8B USD | 2.5 | 17.1 | 7.2 | 8.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
